Primary Device ID | 10190302005265 |
NIH Device Record Key | bd2008ec-1243-4929-9d22-832976d5b316 |
Commercial Distribution Discontinuation | 2022-04-27 |
Commercial Distribution Status | Not in Commercial Distribution |
Brand Name | Human CD3 TRI-COLOR®/CD4 R-PE/CD8 FITC Conjugate |
Version Model Number | CD348A |
Company DUNS | 080131636 |
Company Name | LIFE TECHNOLOGIES CORPORATION |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 10190302005265 [Primary] |
GKZ | Counter, differential cell |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 5 |
Public Version Date | 2022-05-23 |
Device Publish Date | 2016-08-01 |
10190302005197 - Aim -V™ Medium | 2024-06-04 AIM V MED |
10190302012041 - Human CD99 FITC Conjugate | 2024-06-04 HU CD99 3B2/TA8 FITC MAB |
10190302012058 - Human CD99 R-PE Conjugate | 2024-06-04 HU CD99 3B2/TA8 PE MAB |
10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04 HU CXCR4 12G5 PE MAB |
10190302012164 - Anti-Human HLA-DR (Class II) FITC Conjugate | 2024-06-04 HU HLA-DR TU36 FITC MAB |
10190302012171 - Anti-Human HLA-DR (Class II) R-PE Conjugate | 2024-06-04 HU HLA-DR TU36 PE MAB |
10190302012188 - Anti-Human HLA-DR (Class II) APC Conjugate | 2024-06-04 HU HLA-DR TU36 APC MAB |
10190302012195 - Anti-Human HLA-DR (Class II) PE-Texas Red® Conjugate | 2024-06-04 HU HLA-DR TU36 PE-TX RED MAB |